# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-09T02:38:57.819155
**Route:** OpenRouter + LaTeX
**Paper Hash:** c76ac7213228f615
**Tokens:** 18301 in / 1929 out
**Response SHA256:** cd033dcae38451b5

---

I do not find any fatal errors in the draft under the categories you specified.

I checked the following:

- Treatment years versus data coverage:
  - Long/combined panel covers 1999–2017 and 2019–2024.
  - Treated states in the main combined analysis are consistent with available years.
  - Connecticut is excluded because adoption is in 1999, the first panel year, so no pre-period.
  - Short-panel treated states are restricted to 2019–2024 adopters, which is consistent with the 2019–2024 data.

- Post-treatment observations:
  - Combined panel has post-treatment observations for all included treated cohorts.
  - Short panel has post-treatment observations for all 9 included cohorts, including Minnesota (2024) with one post year.

- Treatment definition consistency:
  - The treatment timing described in the text matches Appendix Table “ERPO Law Adoption Timeline.”
  - Counts are consistent: 22 enacted, 21 in estimation sample after excluding Connecticut.

- Regression sanity:
  - No impossible values in any regression tables.
  - No missing/NA/Inf/NaN values in reported estimates.
  - No negative SEs.
  - No R² violations.
  - No coefficients or SEs that meet your fatal thresholds.

- Completeness:
  - Regression tables report N.
  - Standard errors and confidence intervals are reported.
  - Referenced tables/figures/appendices appear to exist in the source.
  - No placeholder text such as TBD/TODO/XXX/NA in results tables.

- Internal consistency:
  - Main reported estimates in text match the corresponding tables.
  - Sample counts and cohort counts are internally consistent across sections.
  - Timing descriptions are consistent across introduction, data, and appendix.

ADVISOR VERDICT: PASS